HIF1A and cancer: Cancer cells exploit this dysregulated protein degradation, mediated through the SMURF2-HIF1α pathway, to diminish cellular levels of proteins essential for the accurate repair of DNA damage or maintaining signal transduction fidelity, leading to an increased capacity for DNA repair and altered responsiveness to mutation-targeted therapies.